Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ads....

ads....

posted on Jun 05, 2006 05:26PM
The TPL pr may not have been as specific but Leckrone did bring up the discount phrase again. It will be nice when the word ``discount`` does not appear in any pr involving, including or indirectly mentioning PTSC and the MMP.

Leckrone confirmed that Alliacense is currently in discussions with dozens of companies, and that competition for early-round licensing berths in key market sectors has become intense. “The MMP Portfolio Licensing Program rewards first movers in their industry sectors with substantial discounts.”

Best to you

marc

Share
New Message
Please login to post a reply